Symbol
| FBLN1
| contributors: mct - updated : 20-02-2019
|
HGNC name
| fibulin 1
|
HGNC id
| 3600
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
| translocation
|  
|  
|
translocation t(12;22)(p11.2;q13.3) in a complex type of synpolydactyly | constitutional
|  
|  
|  
|  
|
haploinsufficence of variant D in synpolydactyly | tumoral
|  
|  
| --over
|  
|
of FBLN1C and FBLN1D in ovarian cancer | constitutional
|  
|  
|  
| loss of function
|
of variant D in autosomal-dominant giant platelet syndromes(FTNS) | tumoral
|  
|  
| --low
|  
|
promoter hypermethylation of FBLN1 is associated with tumor progression in cutaneous melanoma | tumoral
|  
|  
| --low
|  
|
in renal cell carcinoma through promoter hypermethylation | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| serum FBLN1 and STK31 are biomarkers of colorectal cancer, having ability to noninvasively differentiate colorectal cancer from benign polyps | |
changes in VIM and FBLN1 methylation levels in cell-free DNA (cfDNA) are associated with Hepatocellular carcinoma (HCC) and could represent useful plasma-based biomarkers | |
plasma levels of FBLN1 could serve as a potential indicator to monitor kidney malfunction or kidney damage | Therapy target
| | |
| Fbln1c-/- mice also had reduced airway remodeling in experimental chronic asthma and pulmonary fibrosis | |
Fbln1c-deficient (-/-) mice had reduced pulmonary remodeling/fibrosis and improved lung function after bleomycin challenge |